Phosphorylation

Core Concept

Protein phosphorylation is the covalent addition of a phosphate group to a protein — most commonly to the hydroxyl side chains of serine, threonine, or tyrosine — catalyzed by protein kinases and reversed by protein phosphatases. It is the most widespread post-translational modification and the primary language of intracellular signaling. By adding a bulky, doubly negative-charge group, phosphorylation changes a protein's conformation, activity, interactions, or localization, often within seconds, making it a fast, reversible, and switch-like regulator of virtually every cellular process.

Key Components

• Protein kinases — enzymes that transfer the γ-phosphate of ATP to a protein substrate (e.g., protein kinase A, MAP kinases, CDKs, receptor tyrosine kinases).
• Protein phosphatases — enzymes that hydrolyze the phosphoester bond to remove the phosphate (e.g., PP1, PP2A).
• ATP — the phosphate donor; the γ-phosphate is transferred to the substrate.
• Target residues — serine, threonine (serine/threonine kinases) and tyrosine (tyrosine kinases); some kinases are dual-specificity.
• Phospho-binding domains — e.g., SH2, 14-3-3 proteins, that read the modification and propagate the signal.
• Kinase cascades — sequential phosphorylation of one kinase by another (e.g., MAPK cascade), amplifying signals.

Mechanism

A kinase positions ATP and the substrate so the γ-phosphate of ATP is transferred to the target hydroxyl, forming a phosphoester bond and releasing ADP. The added phosphate (with its two negative charges at physiological pH) can stabilize a new conformation, create or block a binding site, or alter catalytic activity. Phosphatases reverse this by hydrolyzing the bond, regenerating the unmodified protein and inorganic phosphate. Because each phosphorylation event is a binary, enzyme-catalyzed toggle, the net state of a protein reflects the local balance of kinase and phosphatase activity.

How It Works

1. A signal (hormone, growth factor, stress) activates a kinase directly or through a cascade.
2. The kinase binds its substrate and transfers the γ-phosphate of ATP to a specific Ser/Thr/Tyr residue.
3. The added phosphate induces a conformational change or creates a docking site for phospho-binding domains.
4. Downstream effectors bind or are released, changing enzyme activity, protein–protein interactions, or localization.
5. The signal is propagated or amplified (e.g., one activated kinase phosphorylates many substrates).
6. Phosphatases remove the phosphate, returning the protein to its basal state and terminating the signal.

Energy and Directionality

Phosphorylation is energetically costly and directional in an important sense: each event consumes one ATP (hydrolyzed to ADP), so a protein cannot phosphorylate itself without energy input, and the modification is always installed by the forward (kinase) reaction and removed by the opposing (phosphatase) reaction. This creates directionality and reversibility — a signaling pathway flows "uphill" when kinases dominate and is reset "downhill" by phosphatases. The large free-energy change of ATP hydrolysis makes phosphorylation effectively irreversible until a phosphatase acts.

Experimental Evidence

• Glycogen phosphorylase (Krebs & Fischer) — showed that phosphorylation converts the enzyme between active and inactive forms, earning a Nobel Prize and establishing phosphorylation as a regulatory mechanism.
• ³²P-labeling — incubating cells with radioactive ATP/phosphate revealed hundreds of phosphorylated proteins responding to stimuli.
• v-Src and tyrosine kinases — the discovery that the Rous sarcoma virus oncogene encodes a tyrosine kinase linked phosphorylation to cancer.
• Kinase/phosphatase inhibitors — specific inhibitors (e.g., okadaic acid for PP1/PP2A) block dephosphorylation and change pathway output, confirming the balance model.
• Mass spectrometry phosphoproteomics — catalogs thousands of phosphorylation sites and their dynamics globally.

Technique

Phosphorylation is detected with phospho-specific antibodies (Western blot, immunofluorescence), ³²P metabolic labeling, Phos-tag SDS-PAGE (mobility shift), and mass spectrometry–based phosphoproteomics (identify and quantify sites). In vitro kinase assays with [γ-³²P]ATP measure enzyme activity; inhibitors and phosphatase treatment test reversibility.

How it works

1. A signal (hormone, growth factor, stress) activates a kinase directly or through a cascade.
2. The kinase binds its substrate and transfers the γ-phosphate of ATP to a specific Ser/Thr/Tyr residue.
3. The added phosphate induces a conformational change or creates a docking site for phospho-binding domains.
4. Downstream effectors bind or are released, changing enzyme activity, protein–protein interactions, or localization.
5. The signal is propagated or amplified (e.g., one activated kinase phosphorylates many substrates).
6. Phosphatases remove the phosphate, returning the protein to its basal state and terminating the signal.

Common confusions

• "Phosphorylation always activates a protein" — it can also inactivate (e.g., some enzymes), change localization, or mark for degradation.
• "Kinases add phosphate from free phosphate" — the donor is ATP (γ-phosphate), not inorganic phosphate.
• "Phosphorylation is permanent" — phosphatases reverse it, making it a dynamic, reversible switch.
• "Only serine is phosphorylated" — Ser/Thr and Tyr are all common targets.
• "Kinases only act in signaling" — they also regulate metabolism, transcription, the cell cycle, and the cytoskeleton.

Quick review

• Kinase (adds P from ATP) ↔ phosphatase (removes P) = reversible switch.
• Targets Ser/Thr/Tyr hydroxyls; consumes ATP.
• Changes conformation, activity, interactions, localization.
• Phospho-readers: SH2, 14-3-3; cascades (MAPK) amplify.
• Krebs/Fischer glycogen phosphorylase; oncogenic tyrosine kinases.
• Dysregulation → cancer; kinase inhibitors are key drugs.